Prognosis and risk stratification in patients with decompensated heart failure receiving inotropic therapy.

Clara GomesCaíque Bueno TerhochSilvia Moreira Ayub-FerreiraGermano Emilio Conceição-SouzaVera Maria Cury SalemiPaulo Roberto ChizzolaMucio Tavares OliveiraSilvia Helena Gelas LageFernando FrioesEdimar Alcides BocchiVictor Sarli Issa

Published in: Open heart (2018)

Inotropic drugs are still widely used in patients with advanced decompensated HF and are associated with a worse in-hospital prognosis. In contrast with previous results, intermittent use of inotropes during hospitalisation did not determine a worse prognosis at 180-day follow-up. These data may add to prognostic evaluation in patients with advanced HF in centres where mechanical circulatory support is not broadly available.

Keyphrases

heart failure
acute heart failure
magnetic resonance
healthcare
left ventricular
atrial fibrillation
ejection fraction
computed tomography
cardiac resynchronization therapy
emergency department
high intensity
liver failure
big data
adverse drug
bone marrow
mesenchymal stem cells
deep learning